Pascal Soriot, lamenter of low pay, faces investor revolt for being overcompensated

AstraZeneca CEO Pascal Soriot once bemoaned his $13 million annual salary, calling himself the “lowest-paid CEO in the whole industry.”

Now, after his new, $18.5 million package came to light last month, AstraZeneca’s investors are complaining: They think Soriot is overpaid.